Imaging of the brain in children with type I diabetes mellitus

Pediatric Radiology

Volumn 37, Issue 9, 2007, Pages 863-869

  Wootton Gorges, Sandra L ^a   Glaser, Nicole S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California at Davis School of Medicine   (United States)

Author keywords

Brain; Children; Diabetes mellitus; Imaging; Review

Indexed keywords

LACTIC ACID;

BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN DISEASE; BRAIN DYSFUNCTION; BRAIN EDEMA; BRAIN FUNCTION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN LEVEL; CHILD; CHILD CARE; CHILDHOOD MORTALITY; DIABETIC KETOACIDOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HUMAN; HYPOGLYCEMIA; IMAGE ANALYSIS; INSULIN DEPENDENT DIABETES MELLITUS; MATERNALLY INHERITED DIABETES AND DEAFNESS; MORBIDITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; WOLFRAM SYNDROME;

BRAIN; CEREBROVASCULAR DISORDERS; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547602335     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-007-0536-8     Document Type: Review

References (71)

1. Styne DM, Glaser NS (1998) Endocrine disorders: Diabetes mellitus. In: Behrman RE, Kliegman R (eds) Nelson essentials of pediatrics, 3rd edn, W.B. Saunders, Philadelphia, pp 679-687
2. Sperling MA (1984) Diabetic ketoacidosis. Pediatr Clin North Am 31:591-610
3. Glaser N (2006) New perspectives on the pathogenesis of cerebral edema complicating diabetic ketoacidosis in children. Pediatr Endocrinol Rev 4:379-386
4. Edge J, Hawkins M, Winter D et al (2001) The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 85:16-22
5. Dunger DB, Sperling MA, Acerini CL et al (2004) ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 89:188-194
6. Rosenbloom AL (1990) Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 13:22-33
7. Glaser N, Barnett P, McCaslin I et al (2001) Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med 344:264-269
8. Carlotti AP, Bohn D, Halperin ML (2003) Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis. Arch Dis Child 88:170-173
9. Lawrence SE, Cummings EA, Gaboury I et al (2005) Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr 146:688-692
10. Bohn D, Daneman D (2002) Diabetic ketoacidosis and cerebral edema. Curr Opin Pediatr 14:287-291
11. Levitsky LL (2004) Symptomatic cerebral edema in diabetic ketoacidosis: the mechanism is clarified but still far from clear. J Pediatr 145:149-150
12. Glaser N (2001) Cerebral edema in children with diabetic ketoacidosis. Curr Diab Rep 1:41-46
13. Muir AB, Quisling RG, Yang MCK et al (2004) Cerebral edema in childhood diabetic ketoacidosis. Diabetes Care 27:1541-1546
14. Osborn AG (1994) Diagnostic neuroradiology. Mosby Year Book, St. Louis, pp 230-231
15. Rogers B, Sills I, Cohen M et al (1990) Diabetic ketoacidosis: neurologic collapse during treatment followed by severe developmental morbidity. Clin Pediatr (Phila) 29:451-456
16. Hoffman WH, Casanova MF, Bauza JA et al (1999) Computer analysis of magnetic resonance imaging of the brain in children and adolescents after treatment of diabetic ketoacidosis. J Diabetes Complications 13:176-181
17. Cameron FJ, Kean MJ, Wellard RM et al (2005) Insights into the acute cerebral metabolic changes associated with childhood diabetes. Diabetes Med 22:648-653
18. Bonkowsky JL, Filloux FM (2003) Extrapontine myelinolysis in a pediatric case of diabetic ketoacidosis and cerebral edema. J Child Neurol 18:144-147
19. Glaser NS, Wootton-Gorges SL, Buonocore MH et al (2006) Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes 7:75-80
20. Krane EJ, Rockoff MA, Wallman JK et al (1985) Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Eng J Med 312:1147-1151
21. Hoffman WH, Steinhart CM, El Gammal T et al (1988) Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR 9:733-739
22. Durr JA, Hoffman WH, Sklar AH et al (1992) Correlates of brain edema in uncontrolled IDDM. Diabetes 41:627-632
23. Glaser NS, Wootton-Gorges SL, Marcin JP et al (2004) Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 145:164-171
24. Figueroa RE, Hoffman WH, Momin Z et al (2005) Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps. Endocr Res 31:345-355
25. Isales C, Min L, Hoffman W (1999) Acetoacetate and B-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabetes Complications 13:91-97
26. Edge J (2000) Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer to finding a cause? Diabetes Metab Res Rev 16:316-324
27. Brubaker LM, Smith JK, Lee YZ et al (2005) Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR 26:825-830
28. Silver SM, Clark EC, Schroeder BM et al (1997) Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney Int 51:1237-1244
29. Wootton-Gorges SL, Buonocore MH, Kuppermann N et al (2005) Detection of cerebral b-hydroxybutyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis. AJNR 26:1286-1291
30. Wootton-Gorges SL, Buonocore MH, Kuppermann N et al (2007) Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis. AJNR 28:895-899
31. Saunders DE, Howe FA, van den Boogaart A et al (1995) Continuing ischaemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 26:1007-1013
32. Saunders DE (2000) MR spectroscopy in stroke. Br Med Bull 56:334-345
33. Bizzi A, Ulug AM, Crawford TO et al (2001) Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR 22:1125-1130
34. Nakamura S, Yoshinari M, Wakisaka M et al (2000) Ketoacidosis accompanied by epileptic seizures in a patient with diabetes mellitus and mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetes Metab 26:407-410
35. Müller-Hartmann W, Herminghaus S, Krings T et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381
36. Gasparovic C, Rosenberg GA, Wallace JA et al (2001) Magnetic resonance lipid signals in rat brain after experimental stroke correlate with neutral lipid accumulation. Neurosci Lett 301:87-90
37. Auer RN (1986) Progress review: Hypoglycemic brain damage. Stroke 17:699-708
38. Dolinak D, Smith C, Graham DI (2000) Hypoglycemia is a cause of axonal injury. Neuropathol Appl Neurobiol 26:448-453
39. Jung SL, Kim BS, Lee KS et al (2005) Magnetic resonance imaging and diffusion-weighted imaging changes after hypoglycemic coma. J Neuroimaging 15:193-196
40. Mori F, Nishie M, Houzen H et al (2006) Hypoglycemic encephalopathy with extensive lesions in the cerebral white matter. Neuropathology 26:147-152
41. Lo L, Tan AC, Umapathi T et al (2006) Diffusion-weighted MR imaging in early diagnosis and prognosis of hypoglycemia. AJNR 27:1222-1224
42. Bottcher J, Kunze A, Kurrat C et al (2005) Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 36:e20-e22
43. Aoki T, Sato T, Hasegawa K et al (2004) Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma. Neurology 63:392-393
44. Maekawa S, Aibiki M, Kikuchi K et al (2006) Time-related changes in reversible MRI findings after prolonged hypoglycemia. Clin Neurol Neurosurg 108:511-513
45. Chan R, Erbay S, Oljeski S et al (2003) Hypoglycemia and diffusion-weighted imaging. J Comput Assist Tomogr 27:420-423
46. Wolfram D, Wagener HP (1938) Diabetes mellitus and simple optic atrophy among siblings: Report of four cases. Proc Staff Meet Mayo Clin 13:715-718
47. Page MM, Asmal AC, Edwards CR (1976) Recessive inheritance of diabetes: the syndrome of diabetes insipidus, diabetes mellitus, optic atrophy and deafness. Q J Med 179:505-520
48. Scolding NJ, Kellar-Wood HF, Shaw C et al (1996) Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol 39:352-360
49. Blasi C, Pierelli F, Rispoli E et al (1986) Wolfram syndrome: A clinical, diagnostic and interpretative contribution. Diabetes Care 9:521-528
50. Karasik A, O'Hara C, Srikanta S et al (1989) Genetically programmed selective B-cell loss in diabetic subjects with Wolfram's syndrome. Diabetes Care 12:135-138
51. Polymeropoulos MH, Swift RG, Swift M (1994) Linkage of the genes for Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet 8:95-97
52. Yang MS, Chen CCC, Cheng YY et al (2005) Imaging characteristics of familial Wolfram syndrome. J Formos Med Assoc 104:129-132
53. Rando TA, Horton JC, Layzer RB (1992) Wolfram syndrome: Evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology 42:1220-1224
54. Senee V, Vatterm KM, Delepine M et al (2004) Wolcott-Rallison syndrome. Clinical, genetic and functional study of EIF2AK3 mutations and suggestion of genetic heterogenicity. Diabetes 53:1876-1883
55. de Wit MC, de Coo IF, Julier C et al (2006) Microcephaly and simplified gyral pattern of the brain associated with early onset insulin-dependent diabetes mellitus. Neurogenetics 7:259-263
56. Takeshima T, Nakashima K (2005) MIDD and MELAS: A clinical spectrum. Intern Med 44:276-277
57. Kobayashi Z, Tsunemi T, Maike H et al (2005) A mother and a child with maternally inherited diabetes and deafness (MIDD) showing atrophy of the cerebrum, cerebellum and brainstem on magnetic resonance imaging (MRI). Intern Med 44:328-331
58. Onishi H, Inoue K, Osaka H et al (1992) MELAS associated with diabetes mellitus and point mutation in mitochondrial DNA. No To Shinkei 44:259-264
59. Yang CY, Lam HC, Lee HC et al (1995) MELAS syndrome associated with diabetes mellitus and hyperthyroidism: A case report from Taiwan. Clin Endocrinol (Oxf) 43:235-239
60. Drouet A, Guilloton L, Godinot C et al (2000) Mitochondrial diabetes complicated by or associated with "MELAS" syndrome? Rev Neurol 156:892-895
61. Allard JC, Tilak S, Carter AP (1988) CT and MR of MELAS syndrome. AJNR 9:1234-1238
62. Barkovich AH, Good W, Koch TK et al (1993) Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR 14:1119-1137
63. Castillo M, Kwock L, Green C (1995) MELAS syndrome: Imaging and proton MR spectroscopic findings. AJNR 16:233-239
64. Biessels GJ (1999) Cerebral complications of diabetes: Clinical findings and pathogenetic mechanisms. Neth J Med 54:35-45
65. McCarthy A, Lindgren S, Mengeling M et al (2002) Effects of diabetes on learning in children. Pediatrics 109:E9
66. Franceschi M, Cecchetto R, Minnicucci F et al (1984) Cognitive processes in insulin-dependent diabetes. Diabetes Care 7:228-231
67. Widom B, Simonson D (1990) Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med 112:904-912
68. Rovet JF, Ehrlich RM, Hoppe M (1987) Intellectual deficits associated with early onset of insulin-dependent diabetes mellitus in children. Diabetes Care 10:510-515
69. Ferguson SC, Blane A, Wardlaw J et al (2005) Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28:1431-1437
70. Araki Y, Nomura M, Tanaka H et al (1994) MRI of the brain in diabetes mellitus. Neuroradiology 36:101-103
71. Lunetta M, Damanti AR, Fabbri G et al (1994) Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J Endocrinol Invest 17:241-245